StrideBio, Inc
Durham, United States (US) · Health and Medical
Do your work at StrideBio, Inc?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
StrideBio, Inc is a gene therapy company based in Durham, North Carolina, dedicated to developing innovative genetic medicines.
We specialize in creating and manufacturing advanced AAV vectors – structure-inspired adeno-associated viruses – to overcome limitations of existing gene therapies. Our proprietary platform enhances vector characteristics, including improved tissue targeting and potency, enabling more effective treatments for patients with monogenic rare diseases and beyond.
StrideBio’s state-of-the-art facility in Research Triangle Park allows us to conduct cutting-edge research and in-house AAV manufacturing, positioning us to generate best-in-class genetic medicines and improve patient outcomes.
We specialize in creating and manufacturing advanced AAV vectors – structure-inspired adeno-associated viruses – to overcome limitations of existing gene therapies. Our proprietary platform enhances vector characteristics, including improved tissue targeting and potency, enabling more effective treatments for patients with monogenic rare diseases and beyond.
StrideBio’s state-of-the-art facility in Research Triangle Park allows us to conduct cutting-edge research and in-house AAV manufacturing, positioning us to generate best-in-class genetic medicines and improve patient outcomes.
Contact Details
+1919-213-7300
info@stridebio.com
Durham, United States (US), 5 Laboratory Dr
Founded
2015
Company Type
Private Limited Company
Employees
50-100
Categories
Keywords
#gene therapy
#aav vectors
#biotechnology
Companies teams usually look at after StrideBio, Inc
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.